SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSosandar Regulatory News (SOS)

Share Price Information for Sosandar (SOS)

Share Price is delayed by 15 minutes
Get Live Data
11.00    0.00 (0.00%)
Bid:
10.50
Ask:
11.50
Spread: 1.00 (9.524%)
Market Cap: £24.00m
SOS Live PriceLast checked at - London Stock Exchange

Intraday Sosandar Share Chart

Director/PDMR Shareholding

13 Jul 2009 13:42

RNS Number : 5696V
Medavinci PLC
13 July 2009
 

Medavinci Plc ("Medavinci" or the "Company")

Directors' Dealings

The Company announces that it has received notification of the following Directors' dealings, pursuant to the placing announced on 8 July 2009 (the "Placing") and the admission to trading of the placing shares on 13 July 2009:

Mr Adam Reynolds, chairman, subscribed for 24,250,000 ordinary shares in the Company at 0.1p per share, pursuant to the Placing. This subscription was effected through his shareholding in Diablo Consulting Limited ("Diablo") in which he holds 50 per cent. of the issued share capital. Diablo subscribed for 48,500,000 ordinary shares at 0.1p per share pursuant to the Placing. Following this subscription, the total holding of Adam Reynolds in the Company amounts to 24,250,000 ordinary shares (representing approximately 4.9 per cent. of the issued share capital). 

Mr Glyn Hirsch, director, subscribed for 50,500,000 ordinary shares in the Company at 0.1p per share, pursuant to the Placing. Following this subscription, the total holding of Glyn Hirsch in the Company amounts to 52,500,000 ordinary shares (representing approximately 10.6 per cent. of the issued share capital).

Mr Michael Hough, director, subscribed for 50,000,000 ordinary shares in the Company at 0.1p per share, pursuant to the Placing. Following this subscription, the total holding of Michael Hough in the Company amounts to 52,000,000 ordinary shares (representing approximately 10.5 per cent. of the issued share capital). 

Mr Paul Foulger, finance director, subscribed for 24,250,000 ordinary shares in the Company at 0.1p per share, pursuant to the Placing. This subscription was effected through his shareholding in Diablo Consulting Limited ("Diablo") in which he holds 50 per cent. of the issued share capital. Diablo subscribed for 48,500,000 ordinary shares at 0.1p per share pursuant to the Placing. Following this subscription, the total holding of Paul Foulger in the Company amounts to 24,250,000 ordinary shares (representing approximately 4.9 per cent. of the issued share capital). 

Contact Details:

Medavinci plc

Adam Reynolds Tel: +44 (0) 270 245 1100

Zeus Capital Limited

Ross Andrews Tel +44 (0)161 831 1512

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEAAXDFLANEFE
Date   Source Headline
5th Oct 20232:25 pmRNSHolding(s) in Company
21st Sep 20231:02 pmRNSResult of AGM
25th Aug 20239:45 amRNSNotice of AGM and Posting of Annual Report
11th Jul 20237:00 amRNSFinal Results
4th Jul 20237:00 amRNSNotice of Results and Investor Presentation
17th Apr 20233:13 pmRNSHolding(s) in Company
13th Apr 20232:28 pmRNSHolding(s) in Company
12th Apr 20237:00 amRNSTrading Update & Progress on Growth Strategy
16th Mar 20237:00 amRNSAppointment of Interim Non-Executive Chairman
3rd Mar 20238:12 amRNSDirector/PDMR Dealing
17th Feb 20233:54 pmRNSResult of Retail Offer
17th Feb 20237:00 amRNSClose of Retail Offer
14th Feb 20232:51 pmRNSHolding(s) in Company
13th Feb 202311:55 amRNSHolding(s) in Company
8th Feb 20234:40 pmRNSSecond Price Monitoring Extn
8th Feb 20234:35 pmRNSPrice Monitoring Extension
8th Feb 20231:30 pmRNSResult of Placing
8th Feb 20239:16 amRNSRetail Offer
8th Feb 20237:00 amRNSProposed Placing to raise a minimum of £4 million
6th Feb 20237:00 amRNSDeath of Director
23rd Jan 20237:00 amRNSNew Third Party Arrangement
10th Jan 20237:00 amRNSTrading Update
13th Dec 20227:00 amRNSHalf Year Results
17th Nov 20227:00 amRNSNotice of Results and Investor Presentation
15th Nov 20225:25 pmRNSAIM Rule 17 Schedule 2(g) Update
18th Oct 20227:00 amRNSHalf Year Trading Update
15th Sep 20223:24 pmRNSResult of AGM & Notice of Trading Update
22nd Aug 20227:00 amRNSNotice of AGM and Posting of Annual Report
18th Aug 20227:00 amRNSBoard Changes and Change of Auditor
12th Jul 20227:00 amRNSFinal Results
24th Jun 20227:00 amRNSNotice of Results and Investor Presentation
10th Jun 20223:31 pmRNSDirector/PDMR Shareholding
6th May 202212:55 pmRNSDirector/PDMR Dealing
14th Apr 20227:00 amRNSBoard Appointment
6th Apr 20222:05 pmRNSSecond Price Monitoring Extn
6th Apr 20222:00 pmRNSPrice Monitoring Extension
6th Apr 20227:00 amRNSTrading Update and New Third Party Arrangements
6th Jan 20227:00 amRNSTrading Update
20th Dec 20219:00 amRNSExercise of Warrants and Total Voting Rights
30th Nov 20217:00 amRNSHalf Year Results
12th Nov 20217:00 amRNSNotice of Results
7th Oct 202111:05 amRNSSecond Price Monitoring Extn
7th Oct 202111:00 amRNSPrice Monitoring Extension
7th Oct 20217:00 amRNSHalf Year Trading Update
30th Sep 20211:01 pmRNSResult of AGM
8th Sep 20217:00 amRNSNotice of AGM & Posting of Annual Report
30th Jul 20212:00 pmRNSPrice Monitoring Extension
28th Jul 20212:00 pmRNSPrice Monitoring Extension
22nd Jul 20213:45 pmRNSHolding(s) in Company
21st Jul 20212:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.